Last reviewed · How we verify

NCT05393687

Eccentric Strength Training of Ankle Joint Muscles in Swimming

Completed NA Last updated 26 May 2022
What this trial tests

NA trial testing Eccentric exercise in Resistance Training in 26 participants. Completed in 9 October 2016.

Timeline
2 August 2016
Primary endpoint
9 October 2016
9 October 2016

Quick facts

Lead sponsorIstinye University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment26
Start date2 August 2016
Primary completion9 October 2016
Estimated completion9 October 2016
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istinye University

Who can join

Adults 84 Months to 155 Months, any sex, with Resistance Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to investigate the effectiveness of ankle muscle strengthening program of 8 weeks on the underwater dolphin kick performance in young swimmers. This study was a randomized controlled trial. Swimmers was divided in two groups; eccentric ankle muscle-strengthening exercises and control group. The outcome measures were strength of plantar flexors, dorsal flexors, internal rotators, external rotators and 5-meter underwater dolphin kick time.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Eccentric exercise

Trials testing the same drug.

Other recruiting trials for Resistance Training

Currently open trials in the same condition.

Other Istinye University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05393687.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing